EvoNext Holdings S.A.
EvoNext Holdings S.A. (EVE.SW) Stock Competitors & Peer Comparison
See (EVE.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EVE.SW | CHF 0.83 | -8.79% | 6M | -6.92 | -CHF 0.12 | N/A |
| GILD.SW | CHF 110.83 | -3.44% | 137.6B | 20.62 | CHF 5.38 | +2.30% |
| BION.SW | CHF 44.40 | -0.11% | 2.4B | 4.21 | CHF 10.54 | +5.07% |
| MOR.SW | CHF 102.00 | +0.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| KURN.SW | CHF 23.24 | +4.40% | 910.5M | 387.33 | CHF 0.06 | N/A |
| IDIA.SW | CHF 3.61 | +4.03% | 720.5M | -6.94 | -CHF 0.52 | N/A |
| BSLN.SW | CHF 54.70 | +0.55% | 671.3M | 17.42 | CHF 3.14 | N/A |
| NWRN.SW | CHF 15.50 | +2.24% | 310.2M | -25.41 | -CHF 0.61 | N/A |
| SANN.SW | CHF 16.38 | +5.27% | 230.2M | -3.04 | -CHF 5.38 | N/A |
| MOLN.SW | CHF 3.05 | -2.24% | 114.1M | -1.85 | -CHF 1.65 | N/A |
Stock Comparison
EVE.SW vs GILD.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, GILD.SW has a market cap of 137.6B. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while GILD.SW trades at CHF 110.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas GILD.SW's P/E ratio is 20.62. In terms of profitability, EVE.SW's ROE is -0.13%, compared to GILD.SW's ROE of +0.26%. Regarding short-term risk, EVE.SW is more volatile compared to GILD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check GILD.SW's competition here
EVE.SW vs BION.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, BION.SW has a market cap of 2.4B. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while BION.SW trades at CHF 44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas BION.SW's P/E ratio is 4.21. In terms of profitability, EVE.SW's ROE is -0.13%, compared to BION.SW's ROE of -0.13%. Regarding short-term risk, EVE.SW is more volatile compared to BION.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check BION.SW's competition here
EVE.SW vs MOR.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, MOR.SW has a market cap of 2.4B. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while MOR.SW trades at CHF 102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas MOR.SW's P/E ratio is -4.03. In terms of profitability, EVE.SW's ROE is -0.13%, compared to MOR.SW's ROE of -1.84%. Regarding short-term risk, Volatility data is not available for a full comparison. EVE.SW has daily volatility of 8.98 and MOR.SW has daily volatility of N/A.Check MOR.SW's competition here
EVE.SW vs KURN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, KURN.SW has a market cap of 910.5M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while KURN.SW trades at CHF 23.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas KURN.SW's P/E ratio is 387.33. In terms of profitability, EVE.SW's ROE is -0.13%, compared to KURN.SW's ROE of +0.02%. Regarding short-term risk, EVE.SW is more volatile compared to KURN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check KURN.SW's competition here
EVE.SW vs IDIA.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, IDIA.SW has a market cap of 720.5M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while IDIA.SW trades at CHF 3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas IDIA.SW's P/E ratio is -6.94. In terms of profitability, EVE.SW's ROE is -0.13%, compared to IDIA.SW's ROE of +0.10%. Regarding short-term risk, EVE.SW is more volatile compared to IDIA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check IDIA.SW's competition here
EVE.SW vs BSLN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, BSLN.SW has a market cap of 671.3M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while BSLN.SW trades at CHF 54.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas BSLN.SW's P/E ratio is 17.42. In terms of profitability, EVE.SW's ROE is -0.13%, compared to BSLN.SW's ROE of +0.28%. Regarding short-term risk, EVE.SW is more volatile compared to BSLN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check BSLN.SW's competition here
EVE.SW vs NWRN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, NWRN.SW has a market cap of 310.2M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while NWRN.SW trades at CHF 15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas NWRN.SW's P/E ratio is -25.41. In terms of profitability, EVE.SW's ROE is -0.13%, compared to NWRN.SW's ROE of +2.78%. Regarding short-term risk, EVE.SW is more volatile compared to NWRN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check NWRN.SW's competition here
EVE.SW vs SANN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, SANN.SW has a market cap of 230.2M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while SANN.SW trades at CHF 16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas SANN.SW's P/E ratio is -3.04. In terms of profitability, EVE.SW's ROE is -0.13%, compared to SANN.SW's ROE of -5.22%. Regarding short-term risk, EVE.SW is more volatile compared to SANN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check SANN.SW's competition here
EVE.SW vs MOLN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, MOLN.SW has a market cap of 114.1M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while MOLN.SW trades at CHF 3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas MOLN.SW's P/E ratio is -1.85. In terms of profitability, EVE.SW's ROE is -0.13%, compared to MOLN.SW's ROE of -0.60%. Regarding short-term risk, EVE.SW is less volatile compared to MOLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVE.SW.Check MOLN.SW's competition here
EVE.SW vs MMTX.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, MMTX.SW has a market cap of 53.4M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while MMTX.SW trades at CHF 0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas MMTX.SW's P/E ratio is N/A. In terms of profitability, EVE.SW's ROE is -0.13%, compared to MMTX.SW's ROE of N/A. Regarding short-term risk, EVE.SW is less volatile compared to MMTX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVE.SW.Check MMTX.SW's competition here
EVE.SW vs RLF.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, RLF.SW has a market cap of 36.3M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while RLF.SW trades at CHF 2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas RLF.SW's P/E ratio is -2.12. In terms of profitability, EVE.SW's ROE is -0.13%, compared to RLF.SW's ROE of -0.49%. Regarding short-term risk, EVE.SW is more volatile compared to RLF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check RLF.SW's competition here
EVE.SW vs ADXN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, ADXN.SW has a market cap of 6M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while ADXN.SW trades at CHF 0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas ADXN.SW's P/E ratio is -0.67. In terms of profitability, EVE.SW's ROE is -0.13%, compared to ADXN.SW's ROE of -0.78%. Regarding short-term risk, EVE.SW is less volatile compared to ADXN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVE.SW.Check ADXN.SW's competition here
EVE.SW vs SPEX.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, EVE.SW's ROE is -0.13%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, EVE.SW is less volatile compared to SPEX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVE.SW.Check SPEX.SW's competition here
EVE.SW vs OBSN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, EVE.SW's ROE is -0.13%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, EVE.SW is less volatile compared to OBSN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVE.SW.Check OBSN.SW's competition here
EVE.SW vs POLN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, EVE.SW's ROE is -0.13%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, EVE.SW is more volatile compared to POLN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for EVE.SW.Check POLN.SW's competition here
EVE.SW vs SKIN.SW Comparison April 2026
EVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EVE.SW stands at 6M. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, EVE.SW is priced at CHF 0.83, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EVE.SW currently has a P/E ratio of -6.92, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, EVE.SW's ROE is -0.13%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, EVE.SW is less volatile compared to SKIN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVE.SW.Check SKIN.SW's competition here